<DOC>
	<DOCNO>NCT03005769</DOCNO>
	<brief_summary>This observational , retrospective , non-interventional study include schizophrenic patient initiated aripiprazole once-monthly per normal clinical practice least 6 month data collection start ( inclusion visit ) , design evaluate demographic clinical predictor persistence treatment . Data patient collect informed consent sign ( inclusion visit ) , include retrospective information start aripiprazole once-monthly treatment initiation ( index date ) follow-up/inclusion visit ( minimum 6 month index date ) . Data retrospectively collect visit occur per clinical practice ( usually monthly ) .</brief_summary>
	<brief_title>Demographic Clinical Predictors Persistence Patients Treated With Aripiprazole Once-monthly Italy</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>1 . Adult patient ( age â‰¥ 18 year time aripiprazole oncemonthly initiation ) 2 . Male female 3 . Diagnosis schizophrenia accord Diagnostic Statistical Manual Mental Disorders , Fifth edition ( DSM5 ) , available start aripiprazole oncemonthly treatment , confirm current investigator 4 . Aripiprazole oncemonthly initiation ( least 1 injection ) accord clinical practice , least 6 month inclusion June 1st 2015 later date ( index date ) 5 . Aripiprazole oncemonthly main antipsychotic time treatment initiation 6 . Willingness participate study ; subject must give write consent participate 1 . The patient psychiatric disorder schizophrenia primary diagnosis 2 . Participation clinical trial retrospective followup period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>persistence</keyword>
	<keyword>long-acting injectable antipsychotic</keyword>
	<keyword>adherence</keyword>
</DOC>